As for axonal Charcot-Marie-Tooth disease, a cohort study from Italy showed that HSPB1 mutation account for about 4% clinical identified CMT2 patients [13]. The gene discussed is HSPB1; the disease is Charcot-Marie-Tooth disease type 2.